Clinical relevance of the small intestine as an organ of drug elimination: drug-fruit juice interactions
- PMID: 17269895
- DOI: 10.1517/17425255.3.1.67
Clinical relevance of the small intestine as an organ of drug elimination: drug-fruit juice interactions
Abstract
Most drugs are taken orally. For those intended to act systemically, a significant fraction of the dose can be eliminated during its first passage through a sequence of organs before entry into the general circulation. For some drugs, the degree of first-pass elimination can be large enough such that oral bioavailability is significantly reduced, with the consequent potential for a reduced clinical response. Of these first-pass eliminating organs, the small intestine and liver are the most commonly implicated, in part because they express the highest levels of drug-metabolizing enzymes. For several drugs whose major route of elimination occurs via CYP3A-mediated metabolism, the extent of first-pass metabolism in the small intestine can rival that in the liver. As such, alterations in enteric CYP3A activity alone can significantly influence oral bioavailability. The most extensively studied xenobiotic shown to inhibit only enteric CYP3A is grapefruit juice, the consequences of which can be clinically significant. Although much information has been gained regarding the grapefruit juice effect, progress in the relatively understudied area of drug-diet interactions continues to be sluggish and reactive. In stark contrast, the potential for drug-drug interactions involving any new therapeutic agent must be evaluated, prospectively, before market introduction. To prospectively elucidate mechanisms underlying drug-diet interactions, a multidisciplinary, translational research approach is required, which capitalizes on the collective expertise of drug metabolism scientists and natural products chemists. Such an approach would allow proper between-study comparisons, and ultimately provide conclusive information as to whether specific dietary substances can be taken safely with certain medications.
Similar articles
-
Application of Cryopreserved Human Intestinal Mucosa and Cryopreserved Human Enterocytes in the Evaluation of Herb-Drug Interactions: Evaluation of CYP3A Inhibitory Potential of Grapefruit Juice and Commercial Formulations of Twenty-Nine Herbal Supplements.Drug Metab Dispos. 2020 Oct;48(10):1084-1091. doi: 10.1124/dmd.120.000033. Epub 2020 Jul 27. Drug Metab Dispos. 2020. PMID: 32719085
-
Grapefruit and drug interactions.Prescrire Int. 2012 Dec;21(133):294-5, 297-8. Prescrire Int. 2012. PMID: 23373097
-
Intestinal drug transporter expression and the impact of grapefruit juice in humans.Clin Pharmacol Ther. 2007 Mar;81(3):362-70. doi: 10.1038/sj.clpt.6100056. Epub 2007 Jan 10. Clin Pharmacol Ther. 2007. PMID: 17215845 Clinical Trial.
-
Grapefruit juice and drug interactions. Exploring mechanisms of this interaction and potential toxicity for certain drugs.Geriatrics. 2006 Nov;61(11):12-8. Geriatrics. 2006. PMID: 17112309 Review.
-
[Grapefruit juice: potential drug interaction].Clin Ter. 2005 May-Jun;156(3):97-103. Clin Ter. 2005. PMID: 16048029 Review. Italian.
Cited by
-
Controversial Interactions of Tacrolimus with Dietary Supplements, Herbs and Food.Pharmaceutics. 2022 Oct 10;14(10):2154. doi: 10.3390/pharmaceutics14102154. Pharmaceutics. 2022. PMID: 36297591 Free PMC article. Review.
-
Recommended Approaches for Pharmacokinetic Natural Product-Drug Interaction Research: a NaPDI Center Commentary.Drug Metab Dispos. 2018 Jul;46(7):1041-1045. doi: 10.1124/dmd.117.079962. Epub 2018 May 7. Drug Metab Dispos. 2018. PMID: 29735755 Free PMC article.
-
Selection of Priority Natural Products for Evaluation as Potential Precipitants of Natural Product-Drug Interactions: A NaPDI Center Recommended Approach.Drug Metab Dispos. 2018 Jul;46(7):1046-1052. doi: 10.1124/dmd.118.081273. Epub 2018 May 7. Drug Metab Dispos. 2018. PMID: 29735752 Free PMC article.
-
Salvia miltiorrhiza Roots against Cardiovascular Disease: Consideration of Herb-Drug Interactions.Biomed Res Int. 2017;2017:9868694. doi: 10.1155/2017/9868694. Epub 2017 Apr 3. Biomed Res Int. 2017. PMID: 28473993 Free PMC article. Review.
-
Suspected Interaction of Cranberry Juice Extracts and Tacrolimus Serum Levels: A Case Report.Cureus. 2016 May 16;8(5):e610. doi: 10.7759/cureus.610. Cureus. 2016. PMID: 27335715 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials